Peranan Vitamin E dalam Mencegah Efek Samping Mukokutaneus Isotretinoin
DOI:
https://doi.org/10.55175/cdk.v47i8.585Keywords:
Isotretinoin, vitamin EAbstract
Isotretinoin merupakan pilihan terapi oral yang paling efektif untuk kasus akne vulgaris derajat berat, tidak responsif terhadap terapi konvensional, akne dengan jaringan parut berat, dan akne kronis. Efek samping mukokutaneus paling sering dan tergantung dosis (dose-dependent), diduga berkaitan dengan berkurangnya produksi sebum, berkurangnya ketebalan stratum korneum, dan berubahnya fungsi barier epidermis. ATRA (all-transretinoic acid) dapat meningkatkan ekspresi TRAIL, yang merupakan protein ligan TNF-related menginduksi apoptosis. Vitamin E (-tokoferol) dapat menekan jumlah reseptor ligan apoptosis serta mengatur profil lipid epidermal. Beberapa penelitian menunjukkan vitamin E dapat mengurangi efek samping isotretinoin.
Isotretinoin is the most effective choice of oral therapy for severe acne, acne unresponsive to conventional therapy, severe acne scars, and chronic acne. Mucocutaneous side effects are the most frequently occurring and dose-dependent, thought to be related to reduced sebum production, reduced stratum corneum thickness, and epidermal barrier function. ATRA (all-trans retinoic acid) increases the expression of TRAIL, a TNF-related ligand protein that induces apoptosis. Vitamin E (-tocopherol) can suppress apoptotic ligand receptors and regulate lipid profiles. Several studies show the advantages of vitamin E in reducing side effects of isotretinoin.
Downloads
References
Goldsmith LA, Fitzpatrick TB. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill Professional; 2012.
Burns T, Rook GA, editors. Rook’s textbook of dermatology: in four volumes. 8th ed. Oxford: Wiley-Blackwell; 2010.
Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review: Brzezinski et al. Dermatol Ther. 2017;30(4):e12483.
Al-Suhaibani S. The Impact of Oral Isotretinoin Dryness and Depression on Saudi Women in Qassim Region: A Survey. J Depress Anxiety. 2016;5(4):245–52.
Rademaker M. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol. 2010;51(4):248–253.
Reilly BK, Ritsema TS. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris: J Am Acad Physician Assist. 2015;28(7):34–9.
Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. JDDG J Dtsch Dermatol Ges. 2010;8:S47–S59.
Melnik BC. Apoptosis May Explain the Pharmacological Mode of Action and Adverse Effects of Isotretinoin, Including Teratogenicity. Acta Derm Venereol. 2017 Feb 8;97(2):173–81.
Clarke SB, Nelson AM, George RE, Thiboutot DM. Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications. Dermatol Clin. 2007 Apr;25(2):137–46.
Khanna N, Kubba R. Acne [Internet]. 2014 [cited 2019 May 10]. Available from: http://public.eblib.com/choice/publicfullrecord.aspx?p=4514429
Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1(3):162–169.
Agarwal U, Bhola K, Besarwal R. Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial. Indian J Dermatol Venereol Leprol. 2011;77(6):688.
Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpsoy E. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res. 2007;299(10):467–73.
Eckhart L, Lippens S, Tschachler E, Declercq W. Cell death by cornification. Biochim Biophys Acta. 2013;1833(12):3471–80.
Thiele JJ. Vitamin E: critical review of its current use in cosmetic and clinical dermatology. Dermatol Surg Off Publ Am Soc Dermatol Surg Al [Internet]. 2005 Jul 1 [cited 2019 May 10];31(7 Pt 2). Available from: insights.ovid.com
Keen MA, Hassan I. Vitamin E in dermatology. Indian Dermatol Online J. 2016;7(4):311.
Vitamin E in human skin: Organ-specific physiology and considerations for its use in dermatology - ScienceDirect [Internet]. [cited 2019 May 10]. Available from: https://www.sciencedirect.com/science/article/pii/S009829970700057X?via%3Dihub
Besa EC, Abrahm JL, Bartholomew MJ, Hyzinski M, Nowell PC. Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol. Am J Med. 1990;89(6):739–47.
Dimery IW, Hong WK, Lee JJ, Guillory-Perez C, Pham F, Fritsche HA, et al. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann Oncol Off J Eur Soc Med Oncol. 1997;8(1):85–9.
Kus S, Gün D, Demirçay Z, Sur H. Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris. Int J Dermatol. 2005;44(3):248–51.
Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: A randomized trial. J Am Acad Dermatol [Internet]. [cited 2019 May 10]. Available from: https://www.jaad.org/article/S0190-9622(00)90368-2/fulltext
Goforoushan F, Azimi H, Goldust M. Efficacy of vitamin E to prevent dermal complications of isotretinoin. Pak J Biol Sci. 2013;16(11):548–50.
Fabbrocini G, Cameli N, Lorenzi S, De Padova MP, Marasca C, Izzo R, et al. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients. G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr. 2014 Aug;149(4):441–5.
Sylvester PW. Vitamin E and apoptosis. Vitam Horm. 2007;76:329–56.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
